← FDA Drug Approvals (Drugs@FDA)

ZAFIRLUKAST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING PHARMS · Approved 2022-08-25

Drug application

FDA Application #

ANDA204928

Application type

Abbreviated New Drug Application (Generic)

Brand name

ZAFIRLUKAST

Generic name

Zafirlukast

Active ingredients

ZAFIRLUKAST

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RISING PHARMS

First approval

2022-08-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown